- Español
- Português
- русский
- Français
- 日本語
- Deutsch
- tiếng Việt
- Italiano
- Nederlands
- ภาษาไทย
- Polski
- 한국어
- Svenska
- magyar
- Malay
- বাংলা ভাষার
- Dansk
- Suomi
- हिन्दी
- Pilipino
- Türkçe
- Gaeilge
- العربية
- Indonesia
- Norsk
- تمل
- český
- ελληνικά
- український
- Javanese
- فارسی
- தமிழ்
- తెలుగు
- नेपाली
- Burmese
- български
- ລາວ
- Latine
- Қазақша
- Euskal
- Azərbaycan
- Slovenský jazyk
- Македонски
- Lietuvos
- Eesti Keel
- Română
- Slovenski
- मराठी
- Srpski језик
Phase III clinical trial of COVID-19 vaccine in China has officially started, with no significant side effects among the volunteers
2020-12-04
According to a report by Hurriyet daily News on December 1, Turkish officials said that volunteers in the phase III clinical trial of China's COVID-19 vaccine have been closely monitored and the results so far show no significant side effects.
On September 15, a phase III trial of China's COVID-19 vaccine was launched in Turkey, involving health care workers at high risk of infection and other moderate-risk volunteers. So far, no serious side effects have been reported. Phase III trials of China's COVID-19 vaccine were conducted in 25 centres in 12 provinces in Turkey. Volunteers will receive a second dose 14 days after the first dose. Volunteers will be closely monitored for 28 days after vaccination. After 28 days, the volunteers were called back every week for a year to track their health.
On September 15, a phase III trial of China's COVID-19 vaccine was launched in Turkey, involving health care workers at high risk of infection and other moderate-risk volunteers. So far, no serious side effects have been reported. Phase III trials of China's COVID-19 vaccine were conducted in 25 centres in 12 provinces in Turkey. Volunteers will receive a second dose 14 days after the first dose. Volunteers will be closely monitored for 28 days after vaccination. After 28 days, the volunteers were called back every week for a year to track their health.
